Ajax-Loading

Fresenius SE & Co. KGaA - Price To Sales Ratio

Fresenius SE & Co. KGaA's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 1.15 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Fresenius SE & Co. KGaA's third quarter, the item "Price To Sales Ratio" stands at 1.15. This represents an increase of 6.62 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 40.53 percent compared to the value the year prior.
The 1 year change in percent is 40.53.
The 3 year change in percent is 322.67.

The Serie's long term average value is 0.605. It's latest available value, on 09/30/2025, is 89.66 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +322.67%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Price To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoHCA Holdings Inc - Price To Sales Ratio113,884,643,328.00
LogoTenet Healthcare Corporation - Price To Sales Ratio18,553,710,592.00
LogoIHH Healthcare Bhd - Price To Sales Ratio18,158,397,709.45
LogoAier Eye Hospital Group - Price To Sales Ratio14,878,706,662.89
LogoUniversal Health Services Inc - Price To Sales Ratio14,705,629,184.00